Oregon launches massive melanoma awareness push – 75,000 people enrolled
NCT ID NCT04611568
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a statewide educational campaign in Oregon helps people spot melanoma earlier. Over 75,000 participants, including patients and healthcare providers, receive training and digital materials. Researchers compare Oregon's results with neighboring states that did not get the campaign. The goal is to see if education alone can reduce deaths from melanoma.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this campaign could increase early melanoma detection and reduce deaths in Oregon.
- What could go wrong
- This is an observational study measuring awareness, not a treatment. Results may not lead to direct health improvements or apply to other regions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can new drug cocktails reawaken the immune system against melanoma?
- Could a Six-Month exercise and diet plan shield muscle during melanoma treatment?
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- Can a One-Two punch of immune boosters revive cancer treatment?
- Can a modified herpes virus turn the tide against advanced cancer?
- Can your genes predict your melanoma risk?